CymitQuimica logo

Nimotuzumab (powder)

CAS:

Ref. TM-T9901A-1025

1mg
Discontinued
5mg
Discontinued

Discontinued product. For inquiries about similar products, please fill out our form or email us at .

CymitQuimica logo
Targetmol

Product Information

Name:Nimotuzumab (powder)
Brand:Targetmol
Description:Nimotuzumab (powder) is a humanized IgG1 monoclonal antibody that specifically targets the epidermal growth factor receptor (EGFR), possessing a dissociation constant (KD) of 0.21 nM. It blocks the binding to its ligand by targeting the extracellular domain of EGFR. Nimotuzumab exhibits strong antitumor activity by inducing both antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC), exerting cytolytic effects on target tumors.
Notice:Our products are intended for lab use only. For any other use, please contact us.

Chemical properties

Color/Form:Liquid

Inquiry about discontinued product: Nimotuzumab (powder)

◻️
CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
* Mandatory fields.